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Abstract
Hybrids composed of liposomes (L) and metallic nanoparticles (NP) hold great potential for 
imaging and drug delivery purposes. However, the efficient incorporation of metallic 
nanoparticles into liposomes using conventional methodologies has so far proved to be 
challenging. In this study, we report the fabrication of hybrids of liposomes and hydrophobic 
gold nanoparticles of size 2-4 nm (Au) using a microfluidic assisted self-assembly process. 
The incorporation of increasing amounts of Au nanoparticles into liposomes was examined 
using microfluidics and compared to L-AuNP hybrids prepared by the reverse-phase 
evaporation method. Our microfluidics strategy produced L-AuNP hybrids with a 
homogeneous size distribution, smaller polydispersity index, and a 3-fold increase in loading 
efficiency when compared to those hybrids prepared using the reverse-phase method of 
production. Quantification of the loading efficiency was determined by ultraviolet 
spectroscopy, inductively coupled plasma mass spectroscopy and centrifugal field flow 
fractionation and confirmed qualitatively by transmission electron microscopy. The higher 
loading of gold nanoparticles into the liposomes achieved using microfluidics produced a 
slightly thicker and more rigid bilayer as determined with small angle neutron scattering. 
These observations were confirmed using fluorescent anisotropy and atomic force 
microscopy, respectively. Structural characterization of the liposomal-nanoparticle hybrids 
with cryo-electron microscopy revealed the co-existence of membrane-embedded and 
interdigitated nanoparticle-rich domains suggesting AuNP incorporation through hydrophobic 
interactions. The microfluidic technique that we describe in this study allows for the 
automated production of monodisperse liposomal-nanoparticle hybrids with high loading 
capacity highlighting the utility of microfluidics to improve the payload of metallic 
nanoparticles within liposomes, thereby enhancing their application for imaging and drug 
delivery.
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Introduction
Since their discovery in 1965, liposomes have been widely investigated for various 
therapeutic and imaging applications and are approved for the treatment of several 
clinical conditions in particular for cancer and inflammatory conditions1, 2. Liposomes 
are formed by self-assembly of phospholipid molecules into vesicles that can 
effectively encapsulate hydrophilic drugs in their aqueous core3, 4 and/or incorporate 
compounds into their lipid membrane4, 5, 6. Other advantages that liposomes offer 
include biocompatibility, biodegradability, modification of blood circulation time and 
thereby the pharmacokinetic profile of encapsulated drugs mainly through surface 
modification with PEGylated lipids (i.e. Stealth liposomes)7. As a consequence of 
these properties, it is possible to achieve the selective (passive) delivery of liposomes 
through malformed blood vessels at the disease site (e.g. into a tumour) while at the 
same time ensuring minimum accumulation into healthy tissues8, 9, in this manner the 
safety profile of liposomally-encapsulated drugs, such as doxorubicin, can be 
significantly improved.
In addition to the development of liposomes for therapeutic purposes, the engineering 
of liposomal-metallic nanoparticles hybrids has also attracted considerable interest for 
imaging, photo-thermal and theranostic (i.e. the combining of imaging/diagnosis and 
therapy in one delivery system) applications. One example of the benefits of using 
gold nanoparticles (AuNPs) for imaging and photo-thermal applications is their 
surface plasmon resonance properties10. Specifically, AuNPs can absorb certain 
wavelengths of light resulting in the oscillation of surface electrons and subsequently 
producing a local heating effect. The intensity and duration of this effect can be 
altered by modifying the intensity and duration of the laser beam applied, as well as 
the concentration of AuNPs used11. Incorporating AuNPs into liposomes can improve 
their colloid stability as well as their biological performance12, 13, 14,10, 15, 16, 17, 18, 19, 20. 
Indeed, it is well established that stimuli responsive liposomes can facilitate the site 
specific release of entrapped material in response to external light21, 22.
There are different methods of L-AuNP hybrid fabrication that have been reported by 
ourselves and others14, 23. These can be categorised into three depending on the 
location of metallic NPs relative to the liposomal membrane, namely a) the 
incorporation of small (< 5nm) hydrophobic NPs into the lipid membrane, b) 
encapsulation of hydrophilic NPs into the liposomal aqueous core, and c) surface 
adsorption or complexation mainly through electrostatic interaction or surface 
adsorption. Although several interesting examples of L-AuNP hybrids has been 
developed for either simple colloidal stabilisation14, 24, medical diagnosis25 and stimuli-
responsive applications26, 27, 28, the efficient incorporation of metallic NPs into the 
liposomes remains the main challenge in the use and application of these systems.
Microfluidics has emerged recently as a very promising technology for liposome 
fabrication. Compared to conventional liposome production methods, microfluidics 
offers precise control over liposome size and polydispersity29, 30 and it is a very 
promising method for the preparation of lipid nanoparticles encapsulating 
macromolecules such as siRNA and mRNA 31, 32, 33. Furthermore, this control is 
achieved in a single step without the need for additional post-production processing 
through extrusion or sonication. Very promising examples of liposomal systems with 
high payload capacity of hydrophilic and/or lipophilic drugs have been reported 34, 35, 
36, 37, 38. Moreover, advances in the design of integrated microfluidic devices allow the 
combination of in-line liposome fabrication with other processes such as remote drug 
loading39, and complexation with genetic material such as pDNA and siRNA40. 
.Significantly, liposomes fabricated by microfluidics showed very similar or even 
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improved physicochemical properties and biological functions (such as increased 
transfection efficiency40 and greater drug loading/retention35, 39 compared to 
liposomes prepared by traditional methods, while at the same time minimising the 
steps required during processing saving several hours or days of work39, 41. Here, we 
investigated the possibility of using microfluidics to encapsulate metallic nanoparticles 
in the liposomes for imaging applications or modulation of drug release properties 
when combined with therapeutic molecules. 
In this study we aim to improve the incorporation of metallic NPs into liposomes using 
a microfluidic assisted self-assembly process. For this purpose, hydrophobic AuNPs 
of size 2-4 nm were selected as model nanoparticles for incorporation into liposomes. 
The incorporation of increasing concentrations of AuNPs (0.025, 0.25 and 2.5 mg/mL) 
into liposomes (total lipid concertation is 4.5 mg/ml) were studied using microfluidic 
and directly compared to L-AuNP hybrids prepared by reverse-phase evaporation 
(REV) method. Physicochemical properties, encapsulation capacity, morphology of L-
AuNP hybrids prepared by the two methods were compared. In addition, the effect of 
Au NPs incorporation on the lipid membrane rigidity and thickness was investigated.
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Experimental
Materials 
Hydrogenated soy phosphatidylcholine (HSPC) and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000) were kind 
gifts from Lipoid GmbH (Ludwigshafen, Germany). Chloroform and methanol were 
purchased from Fisher Scientific (Loughborough, UK). 1,6-diphenyl-l,3,5-hexatriene (DPH) 
was supplied from Invitrogen (Paisley, UK). Phosphate buffer saline (PBS), Sepharose CL-
4B, 2 w/v% octanethiol-functionalized Au nanoparticles in toluene, diethyl ether, 8-anilino-1-
naphthalenesulfonic acid (ANS), Aqua regia (HNO3:HCl 1:3 v/v) and tetrahydrofuran were all 
obtained from Sigma-Aldrich (Dorset, UK). MilliQ® water (Millipore Milli-Q, Watford, UK) was 
used throughout the study. D2O (> 99.9% purity) was purchased from Aldrich (Dorset, UK). 
Preparation of L-AuNP Hybrids by Microfluidics Method (MF)
L-AuNP hybrids were self-assembled using the automated microfluidic Asia 320 system 
(Syrris, Royston UK). First, a solution of Au nanoparticles in CHCl3 was prepared by 
evaporating (BÜCHI, Switzerland) toluene in which Au nanoparticles were already dissolved 
and re-suspending the nanoparticles in CHCl3. Three different concentrations of Au 
nanoparticles dispersed in CHCl3 (1mL) were then mixed with a 95:5 mol:mol solution of 
HSPC:DSPE-PEG2000 (pre-dissolved in 1mL MeOH) as shown in Table 1.
Table 1: Theoretical Concentration of Au nanoparticles used for the preparation of L-AuNP 
hybrids.
Formulation   
designation
Total lipid concentration (mg/mL)
HSPC:DSPE-PEG2000 (95:5 mol:mol)
Au nanoparticles 
(AuNPs) (mg/mL)
L-AuNP 0.025 4.5 0.025
L-AuNP 0.25 4.5 0.25
L-AuNP 2.5 4.5 2.5
Following the mixing of the AuNPs with the lipids, CHCl3 was evaporated using a rotary 
evaporator at 460 mbar for 20 min at 40°C. The resulting methanolic suspension of lipids 
and AuNPs was then further diluted with MeOH to a total lipid concentration of 1 mg/mL 
before introducing it into the Asia microfluidics system. Note that preliminary studies had 
showed that higher lipid concentrations than 1 mg/mL resulted in the production of larger 
sized liposomes. Once in the microfluidics set-up, the methanolic mixture containing both the 
lipids and the AuNPs was mixed with an aqueous solution (PBS, pH 7.4) in an Asia 26 J 
micromixer reaction chip (Syrris part number: 2101411 - internal main channel cross section 
of 125x350 µm, internal mixing channel cross section of 50x125 µm). The optimum mixing 
conditions was determined by first exploring different flow rates such that an 
organic:aqueous flow rate ratio (FRR) of either 1:5 or 1:10 was used along with a total flow 
rate (TFR) of either 220, 330, 680, 1370 or 2750 µL/min (as described in Table 2). 
Optimisation was initially explored using plain (empty) liposomes and finalised with L-AuNP 
systems. 
Once prepared, L-AuNP hybrids were then dialysed for 24 h using a Spectra-Por® Float-A-
Lyzer (MWCO of 10 kDa) against PBS in order to remove any residual methanol. Following 
dialysis, a concentration step was performed using centrifugal viva-spin column 20 to 
concentrate the final L-AuNP formulations to a total lipid concentration of 4.5 mg/mL as 
confirmed by the Stewarts assay42.
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Table 2: Microfluidic Parameters Used in the Study. 
Total Flow 
Rate
Organic:Aqueous Flow Rate Ratio (FRR)
Organic:Aqueous = 1:10                                 Organic:Aqueous = 1:5
        (TFR)
       (µL/mL)
Organic flow 
rate (µL/mL)
Aqueous flow 
rate (µL/mL)
Organic flow 
rate (µL/mL)
Aqueous flow 
rate (µL/mL)
220 20 200 45 175
330 30 300 65 265
680 60 620 135 545
1370 120 1250 275 1095
2750 250 2500 550 2200
Preparation of L-AuNP Hybrids by the Reverse-Phase Evaporation Method 
L-AuNP hybrids were prepared using reverse-phase evaporation (REV) methodology as 
previously described43 using the same lipid composition and the same initial concentration of 
Au nanoparticles (i.e. 0.025, 0.25 & 2.5 mg/mL), denoted as L-AuNP 0.025, L-AuNP 0.25 
and L-AuNP 2.5, respectively. In brief, the required amount of hydrophobic AuNP dispersion 
was first added to a round bottom flask. The organic solvent (toluene) in which the AuNPs 
were dispersed was then removed using rotary evaporation at 6 mbar and 40°C for 30 min. 
The lipid mixture of 95:5 molar ratio of HSPC:DSPE- PEG2000, dissolved in a 4:1 v/v mixture 
of chloroform:methanol, was then added and the organic solvent evaporated to form the lipid 
film containing the nanoparticles. The AuNP-containing lipid film was then re-dissolved in 6 
mL of 1:1 v/v chloroform:diethylether. Following this step, 1.5 mL of PBS was added and the 
resultant mixture bath sonicated for 15 min at 40°C after which time the organic solvents 
were removed using rotary evaporation at 460 mbar and 40°C for 2 h. The large unilamellar 
liposomes (LUVs) formed by this process were then reduced in size by 30 min bath 
sonication at 60°C.
Characterization of L-AuNP Hybrids
The apparent hydrodynamic radius and polydispersity index (PDI) of the liposomes were 
measured using Zetasizer Nano ZS (Malvern, Instruments, UK). Measurements were 
performed at 25°C, after dialysis against PBS of the L-AuNP hybrids prepared with 
microfluidics methodology. 
Quantification of lipids concentration by Stewarts assay
The concentration of lipid in the final products was assessed using the Stewart assay42. In 
brief liposome sample (20 µL) was mixed with Stewarts reagent (0.5 mL) and CHCl3 (1 mL). 
The resultant mixture was shaken for 20 sec and centrifuged at 13,793 RCF (Heraeus 
Biofuge 13) and the absorbance of the lipid containing CHCl3 layer was measured at 485 nm 
and compared to a standard curve prepared by plotting the absorbance at 485 nm versus 
lipid concentration in the range between 0.02-5 mg/mL.
Quantification of AuNP Loading Efficiency by Ultra Violet Spectroscopy and 
Inductively Coupled Plasma Mass Spectrometry
The amount of Au, and by implication the amount of AuNPs loaded into the liposomes was 
quantified using both ultraviolet (UV) spectroscopy and mass spectrometry. The UV 
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absorbance of the Au was recorded on Cary 50 UV/VIS (Agilent Technologies, US) with the 
value of the maximum absorbance measured at 510 nm (after correction for any light 
scattering) being used to quantify the amount of Au present by comparison to a standard 
calibration curve. For inductively coupled plasma mass spectrometry (ICP-MS) 
measurements, samples were first dissolved in 1 mL of aqua regia followed by a brief mixing 
for 30 sec. 100 µL of the sample in aqua regia was then diluted with Milli-Q® water up to 5 
mL (thereby making an aqua regia concentration of 2% v/v) before performing ICP-MS 
(Agilent Technologies 7500 cx). L-AuNP hybrids loading efficiencies were then expressed as 
Au/lipid w/w %.
Separation and Characterization of L-AuNP Hybrids Fractions from Plain Liposomes
In order to separate and quantify the fraction of L-AuNP hybrids from the empty or plain 
liposomes contained in each sample, a centrifugation step was applied. Specifically, 
samples of L-AuNP hybrids loaded with different concentrations of Au nanoparticles were 
centrifuged at room temperature for 2 h at 13,793 RCF (Biofuge 13). Characterization of L-
AuNP hybrids fraction (assumed to be the sediment observed under the conditions of the 
test) and the unloaded empty liposomal fraction (assumed to remain suspended in the 
supernatant under the conditions of the test) was performed by measuring the ratio of 
AuNPs/lipids present in each fraction using a combination of UV spectroscopy and the 
Stewarts assay. Any differences in size and PDI between the nanoparticles present in the 
two fractions were also determined as described above. 
Centrifugal Field Flow Fractionation Measurements
Centrifugal field flow fractionation (C-FFF) measurements were performed using a CF2000 
C-FFF system (Postnova Analytics, Landsberg, Germany) which was coupled online to 4 
detection instruments, namely 1) a UV/Vis spectrometer at 500 nm (S3210, Laserchrom, 
Rochester, UK), 2) a multiangle laser light scatterer (MALLS, Viscotek SEC-MALS20, 
Malvern Instruments, Worcestershire, UK) equipped with a laser operating at 532 nm, 3) a 
refractometer (Optilab T-rEX, Wyatt Technology, Dernbach, Germany) equipped with a laser 
operating at 633 nm and 4) a dynamic light scatterer (DLS, Zetasizer Nano SZ, Malvern 
Instruments, Worcestershire, UK). The dimensions of the channel used were channel 
thickness, w = 237 µm, channel area = 100 cm2, void volume (V0) = 2.597 mL, radius of 
rotation (r) = 10.01 cm (according to the manufacturers specification). 
In a typical experiment, 20 uL of sample was loaded in the injector loop and the sample 
injected over 114 sec with a rotor speed equal of 4900 rpm. After 5 min relaxation time, the 
sample was then eluted in PBS at a rate of 0.5 mL/min. The method-wizard of the CF2000 
control software (version 1.0.2.2, Postnova Analytics) was used for automatic decay field 
calculations. The rotor speed at each time point (RPMt) is expressed in equation 1:
(Eq. 1) = 0[
1  
   ]
4
where RPM0 = starting rotor speed, t1 = length of time for which RPM0 is kept constant, t is 
the time expressed in minutes, t+ is an arbitrary constant expressed in minutes that can be 
tuned in order to modulate the decay rate, ttot = decay time (the total duration of the elution 
being ttot + t1). All samples, except for the MF L-AuNP hybrids 2.5, were eluted using the 
following parameters: RPM0 = 4900, t1 = 10, t+ = -21 and ttot = 49. In contrast, the MF L-
AuNP hybrids 2.5 were eluted using parameters of RPM0 = 4900, t1 = 7, t+ = -35 and ttot = 
111.
The apparent hydrodynamic diameter (Z-average size) of the eluted particles was measured 
by DLS in flow mode and the resulting chromatogram was analysed using the DLS analysis 
tool of the Zetasizer Software (version 7.11, Malvern).
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C-FFF allows the separation of particles based on mass and apparent hydrodynamic 
diameter ( )39. According to C-FFF theory, the force applied on a single particle ( ) can be  
expressed as described in equation 2:
 (Eq. 2) =

6

3
where  is the difference in apparent density between L-AuNPs and the solvent in which 
they are dispersed and , the gravitational acceleration is defined as in equation 3;
 (Eq. 3) = (
  
60 )
2

The retention time (tr) is proportional to the force  according to equation 4:
 (Eq. 4) =
0
 
where  = channel thickness,  = void volume,  = Boltzmann coefficient,  = absolute  0   
temperature and  = channel flow rate.  for each time point can, therefore, be  ||
determined from a knowledge of the parameters ,  and , the method used for the elution  0 
(  and ) and the apparent hydrodynamic size of the particles determined during elution.  
Transmission Electron Microscopy and Scanning Transmission Electron Microscopy 
Studies
Transmission electron microscopy (TEM) and scanning transmission electron microscopy 
(STEM) studies were performed by depositing 10 µL of L-AuNP hybrid dispersion onto a 
carbon coated grid and staining with 1% w/v uranyl acetate solution. Excess liquid was 
removed by drying with a wick of filter paper and leaving the grids dry for 10 min. TEM 
images were acquired on a FEI (US) Tecnai 12 Biotwin Transmission Electron Microscope. 
Images were acquired with Gatan Orius SC1000 CCD camera. STEM imaging was carried 
out using a FEI (US) Titan G2 80-200 TEM microscope fitted with a probe side aberration 
corrector, a high brightness X-FEG electron source and operating at 200 kV. 
X-rays energy dispersive spectroscopic (XEDS) measurements were performed on the FEI 
Titan microscope using the FEI SuperX system U 0.7 sR collection angle) with a probe 
current of 360 pA. High-angle annular dark-field (HAADF) images were acquired using an 
inner collection angle of 62 mrad and a probe convergence angle of 21 mrad. Processing the 
XEDS dataset were performed with the HyperSpy software44. Principal component analysis 
was used to denoise the hyperspectral datasets with 3 to 4 components being used to 
reconstruct the data. The Au and Uranium (U) elemental maps were obtained by integration 
of signal in the L lines at 9.71 keV and 13.61 keV, respectively.
Cryo-Transmission Electron Microscopy 
Visualization of the samples with cryo-transmission electron microscopy (Cryo-TEM) was 
performed to study the morphology of L-AuNP hybrids and to confirm the incorporation of 
metallic nanoparticles. Samples were vitrified by applying a 3 J aliquot to a previously glow-
discharged 200-mesh hole and Quantifoil carbon grids (Ted Pella, USA). Grids were blotted 
and then plunged into liquid ethane using a FEI Vitrobot Mark IV (FEI Company, the 
Netherlands). The samples were imaged in bright field transmission electron microscopy 
(TEM) using a Tecnai G2F20 microscope (FEI Company, the Netherlands) equipped with a 
Schottky Field Emission electron source, a US1000 2kx2k Gatan CCD camera and 
operating at an acceleration voltage of 200 kV. The cryo-tomographic (CET) tilt series were 
collected on the vitrified sample by tilting over ± 60° in 2° steps. Computation of tomograms 
and post-processing were performed using the IMOD 4.9.2 software package45. 
Segmentation by isosurface and 3D visualization were undertaken using the Amira package 
(FEI Visualization Science Group, Bordeaux). Cryo-TEM and CET imaging were both 
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9
performed under low dose conditions, with a total dose of 60-80 electrons/Å2 being used for 
the whole tilt series. 
Fluorescence Anisotropy Measurements
Fluorescence anisotropy experiments were performed to study the effect of metallic 
nanoparticles incorporation on the liposomes membrane fluidity. The hydrophobic probe, 
1,6-diphenyl-l,3,5-hexatriene (DPH) and the hydrophilic probe, 8-anilino-1-
naphthalenesulfonic acid (ANS) were used to monitor the changes in the fluidity of the 
hydrophobic region of the lipid membrane and near the liposomes surface, respectively. 
Experiments were performed as previously described46. Briefly, L-AuNP hybrids were further 
diluted to a total lipid of 0.025 mM total and divided into two 4 mL aliquots. Either a DPH in 
tetrahydrofuran solution (0.8 m M, 2.5 µL) or an aqueous ANS solution (10 mM, 4 µL) was 
mixed with the liposomes at 500:1 total lipid/DPH or 25:1 total lipid/ANS. To allow the probes 
to be incorporated, the samples were shaken at room temperature for 2 h and then left 
overnight before starting the measurements. Fluorescence polarization was then measured 
by a Carry Eclipse, Agilent technology equipped with automated polarizer and thermostatic 
cell holder connected to a water bath to control the sample temperature. For the experiments 
utilising DPH, the anisotropy measurements were performed using an excitation wavelength 
of 395 nm (slit of 10 nm) and emission wavelength of 476 nm (slit of 5 nm). Measurements 
were started at 25 °C, and then the temperature was increased gradually up to 65°C at a 
step change of 3°C. The samples were equilibrated for at least 2 min after each temperature 
change. Fluorescence anisotropy was then measured automatically by the 
spectrofluorometer using equation 5;
(eq. 5)r =  
Ivv  GIvH
Ivv + 2GIvH
where r = fluorescence anisotropy and IVV and IVH = the emission intensity excited with 
vertically polarized light and measured with emission polarizer oriented in a parallel or 
perpendicular direction to the plane of excitation, respectively. G = an instrument specific 
factor calculated to correct the instrument polarization, which is equal to IHV/IHH, and obtained 
by measuring the vertically and horizontally polarized emission intensities after excitation 
with horizontally polarized light. A sigmoidal Boltzmann curve was fitted to the experimental 
values were performed using Origin 8.5 software.
Small Angle Neutron Scattering Measurements
Small angle neutron scattering (SANS) measurements on vesicles (prepared using the REV 
methodology) without a NP payload and L-AuNP hybrids prepared by both MF and REV 
methodology were performed using the beam line, SANS2D, at the ISIS pulsed neutron 
source (STFC Rutherford-Appleton Laboratory, Didcot, UK). All samples were prepared in 
PBS and diluted before measurement with an equal volume of PBS in deuterium oxide (D2O) 
in order to provide the contrast (or scattering length density difference) necessary for the 
SANS measurements. The empty lipid vesicles and the L-AuNP hybrids were measured at 
total lipid concentration of 0.5 mg/mL in 1 mL bango cells using a solvent of composition of 
1:1 v/v PBSH2O:PBSD2O and at 25°C. Note that, with the exception of D2O, all the 
components using to make PBSD2O were protiated.
The SANS intensity, I(Q), of the samples were measured as a function of the scattering 
vector as described in equation 6, 
)N$X1Y	Z1" (eq. 6)
were Z1" = the scattering angle. The data were normalised to the appropriate sample 
transmission after subtraction of the scattering of the relevant solvent which was normalised 
to its corresponding transmission. The fitting of the SANS data always included a flat 
background correction to allow for any mismatch in the incoherent and inelastic scattering 
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between the sample and the solvent, with the levels of the fitted background being checked 
to ensure that they were physically reasonable. The SANS data obtained in the present 
study were well modelled assuming a mixture of (isolated/single) infinite planar (lamellar) 
sheets with the addition of one-dimensional paracrystals (stacks) to account for the presence 
in the sample of any multilamellar vesicles. The fits to the SANS data were obtained by the 
least-squares refinement of seven parameters, namely, the mean bilayer thickness (L), the 
Lorentz factor (R/), the number of bilayers in the stack (M), their mean separation or d-
spacing (D), the width of the Gaussian distribution in the plane (/(D)/D), and the absolute 
scale factors for the unilamellar and multilamellar vesicles. During the analysis of the SANS 
data in the present study, the following factors namely, /(L)/L, /(D)/D and R/, were fixed at 
0.1, 0.05 and 200, respectively. The only exception was the L-AuNP prepared using MF 
methodology where the value of R/ had to be increased to 560 to fit satisfactorily fit the data, 
a lower value R/ would not produce a reasonable fit of the data. In addition, when modelling 
the SANS data using a mixed population of sheets and stacks, L, /(L)/L, and R/ were 
constrained to be the same for the isolated/single and stacked lamellae, a not unreasonable 
assumption. All the SANS data were fitted using a multilayer stack comprising of 3-4 
bilayers. For all models, the least-squares refinements were performed using the model-
fitting routines provided in the FISH software47.
Atomic Force Microscopy
Atomic force microscopy (AFM) analysis was performed to study the effect of nanoparticles 
incorporation on the bilayer thickness. L-AuNP hybrid dispersion (20 µL) loaded with 2.5 
mg/mL of Au nanoparticles and formulated via REV or MF methods were deposited on the 
surface of a sheet of freshly cleaved mica and were allowed to adsorb for 1 min. Non-
adsorbed liposomes were washed off by filtered distilled water. Samples were then dried 
with dust-free argon gas. A Molecular Force Probe 3D AFM (MFP-3D, Asylum Research, 
Oxford Instruments, Abingdon, UK) equipped with a ScanAsyst-Fluid cantilever (Bruker, 
Camarillo, CA, USA) was used to acquire the AFM images in air at room temperature in 
tapping mode. The silicon nitride cantilever had a nominal spring constant of 0.7 N/m and a 
typical resonance frequency of 150 kHz. Different areas of the samples (< 10 µm2) were 
imaged at a scan rate and a resolution of 1 Hz and 512 x 512 pixels, respectively. Images 
were analysed with MFP-3D software (Oxford Instrument) and profiles were plotted with 
Origin 8.5 software. 
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Results and Discussion
Fabrication and Physicochemical Characterization of L-AuNP Hybrids
Microfluidics represent a promising technology for the scalable production of both 
nanoparticles and liposomes offering the possibility of a precise control over their size and 
polydispersity as well as the potential to increase drug loading capacity29, 36, 48, 49. When the 
organic and buffered aqueous phases are mixed in a microfluidics system, the polarity of the 
solvent increases gradually when compared to the polarity of the organic solvent in which 
the phospholipids were dissolved. As a consequence, the solubility of the phospholipids 
progressively reduces promoting their self-assembly into planar bilayer disc-like structures. 
These planar structures eventually close-up into spherical vesicles or liposomes36, 50. In the 
present study, L-AuNP hybrids were fabricated through self-assembly using either MF 
(Figure 1A) or REV methodologys (Figure 1B). Specifically the incorporation of three 
different concentrations of AuNPs, namely 2.5, 0.25 and 0.025 mg/mL, into self-assembled 
liposomes comprising of HSPC:DSPE-PEG2000 (95:5) mol/mol has been investigated. To 
obtain the best level of incorporation of AuNP into the lipid bilayer, hydrophobically-
derivatized AuNP of 2-4 nm size were used13, 22. The conditions for the microfluidic 
preparation of the L-AuNP were optimised using an automated Asia 320 microfluidic system 
(Syrris, Royston UK) equipped with an Asia 26 µmixer reaction chip. PBS was selected as 
solvent for the aqueous phase because previous work had found that liposomes composed 
of DSPC lipids have smaller size when prepared in PBS buffer compared to other buffers 
such as Tris buffer36. The choice of the organic solvent plays a crucial role in the defining 
properties of the resultant liposomes including their size and stability. For example, the use 
of methanol, as is the case here, and isopropyl alcohol as solvent produces superior 
liposomes compared to when ethanol was used as solvent. This is the result of the tendency 
of ethanol to promote vesicle fusion and consequently liposome aggregation if it is not 
completely removed51. Methanol was selected as organic solvent for two reasons, namely it 
dissolves both HSPC and DSPE-PEG2000 and because it is miscible with the PBS buffer. 
However, because the hydrophobic AuNPs, supplied suspended in toluene, have a 
tendency to aggregate in methanol, extra steps had to be incorporated into the MF 
preparation process in order to ensure that NPs were fully suspended. Consequently, after 
the evaporation of the toluene dispersing solvent, the AuNPs were re-suspended in CHCl3 
and mixed with the methanolic lipid solution and sonicated for 20 seconds in order to obtain 
a homogenous NPs dispersion. CHCl3 was then removed from the sonicated mixture by 15-
20 min evaporation at 460 mbar and at 40°C before the final AuNP lipid mixture was 
introduced into the microfluidics system. TEM images of the AuNP before and after 
evaporation of toluene and after resuspension in CHCl3 confirmed the absence of AuNP 
aggregates (Figure S1 A&B). HSPC was specifically selected as the major lipidic component 
of the liposomes because earlier studies had demonstrated that lipids with long hydrophobic 
chains exhibited a higher capacity for the incorporation of hydrophobic molecules 52, 53. In the 
same vein, cholesterol was not added to the formulation as it had been shown to reduce 
metallic NP incorporation into lipid bilayers54, 55. However, cholesterol is well known to have a 
significant effect on the structural stability and drug retention inside the liposomes under 
physiological condition. Thus, the effect of cholesterol on metallic NPs loading into the 
liposomes should be considered. 
In agreement with earlier studies, we observed that the FRR, which represents the 
organic:water ratio at the mixing point, affects the size of the liposomes produced. In the 
present study, two FRRs, namely 1:5 and 1:10, were investigated. When the FRR is 
increased from 1:5 to 1:10, the increased volume of the aqueous solvent imposes a dilution 
on the organic solvent facilitating a rapid mixing56 and thereby favouring the formation of 
small liposomes37, 49,54.On the other hand, when a FRR of 1:5 was used, irrespective of the 
TFR and the running temperature, the resultant particles exhibited a bimodal distribution with 
a Z-average size of greater than 800 nm (data not shown). In contrast, when an FRR equal 
to 1:10 was used, liposomes characterised by small sizes and low PDI values were 
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observed when a TFR of less than 680 µL/min and a running temperature of equal to or 
greater than 60°C were used (Figure S1C). This result was contrary to that of other 
researchers56, 57 who have reported that the TFR used has little effect on the final size of the 
liposomes produced. 
Additionally, the size of the liposomes was decreased by an increase in the experimental 
temperature up to 65°C (i.e. the temperature at which the micromixer chip was maintained 
during the mixing of the two phases) to above the Tm of the lipids (~ 50°C) as determined by 
our anisotropy measurements and from previous literature.58, 59 This effect of temperature is 
a consequence of the higher mobility of the phospholipid tails which results in the efficient, 
rapid mixing of the solvents in the chip, especially at the lower FRR. In this context it is worth 
mentioning that for a TFR \ 1370µL/min, the residence time of the solvents in the 
micromixer channels prior to mixing is insufficient to ensure temperature equilibration. 
Therefore, at TFR values above 1370 µL/min (values between 680 and 1370 µL/min were 
not tested) mixing was not favoured mainly because the actual experimental temperature 
was less than Tm. This observation could explain why increasing the TFR above 680µL/min 
resulted in the production of liposomes of an increased size. A better control of the size at 
higher TFR could be possible by simply change the geometry of the mixing chip.
Based on the observations made in the present study, the L-AuNP hybrids were routinely 
prepared using a FRR of 1:10, a TFR of 220 µL/min and a running temperature of 65°C. 
In order to evaluate the benefits and drawbacks of using microfluidic technology for the 
production of L-AuNP hybrids, L-AuNP hybrids of comparable composition to those prepared 
using MF were prepared using REV methodology (Figure 1B),43, 60 a method widely used for 
preparation of L-AuNP hybrids. Significantly, no (liposomal) size reduction step was required 
when using MF methodology, which is an advantage over the REV method which requires a 
reduction in liposomal size, here performed by 30 min of bath sonication at 60°C. 
Characterization of the L-AuNP hybrids using dynamic light scattering (Figures 2A-C) 
showed that the MF methodology produced L-AuNP hybrids with a more homogenous size 
distribution (i.e. a narrower PDI) compared to those prepared using the REV method (Figure 
2D). These size data were confirmed by C-FFF, which showed that the REV method 
resulted in the production of a larger proportion of smaller size liposomes when compared to 
the single homogenous peak of approximately 100 nm recorded for the liposomes prepared 
using the MF method (Figure 2E). 
The ability to finely tune all these parameters in the microfluidics set-up enables controlled 
mixing of the liquid interfaces to achieve the desired properties (e.g. size and PDI) of the 
final liposomes product. This can be achieved in a single process without the need for post-
processing or changing the lipid composition of the liposomes30, 35. Cancer therapy is one 
example where size reduction of liposomes is desirable34. A recent study by Dong et al 
demonstrated that by using MF methodology it was possible to reduce the size of 
doxorubicin-loaded liposomes to 50 nm. As a result of that, improvement in tumour 
extravasation and intra-tumoral distribution was observed 34. 
Quantification of L-AuNP Hybrids Loading by UV-Vis and ICP-MS 
Another advantage of the microfluidic production of liposomes is the enhanced capacity for 
their payload of therapeutic molecules. Interestingly, the payload capacity of hydrophilic 
drugs is almost doubled with MF technology compared to less than 10% obtained by 
traditional liposomes preparation methods.1 Moreover, MF technology is highly efficient for 
incorporation of poorly water soluble drugs into the liposomes and has demonstrated  the 
potential for entrapping both hydrophilic and lipophilic drugs simultaneously. Efficient loading 
of wide range of therapeutics has been reported. These include hydrophilic molecules (e.g. 
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metformin, sulforhodamine)36, 61 and hydrophobic molecules (e.g. glipizide and propofol)36,58 
either individually or in combination36. The aim of the present study was to explore the use of 
microfluidics for the fabrication of L-AuNP hybrids due to the poor payload capacity reported 
with other traditional methods.62 The quantification of AuNPs embedded in the liposomes 
was performed using UV-VIS spectrometry (Figure 3A & Figure S2) and ICP-MS (Figure 
3B). Regardless of which of the assay methods was used, an increase in AuNP loading into 
the liposomes with increasing the initial AuNP concentration was observed. Significantly, a 
3-fold increase in loading efficiency was observed in the hybrid systems prepared by MF 
methodology when compared to the REV method at the highest initial concentration of AuNP 
examined, i.e. 2.5 mg of AuNPs. In comparison, no difference in the AuNP loading capacity 
between the two methods was observed at the lower initial AuNP concentrations of 0.025 
and 0.25 mg, although qualitative differences (discussed in the next paragraph) were 
observed in TEM images (Figures 4 A and B).
Size exclusion chromatography (SEC) was used to separate AuNPs that were not 
incorporated into liposomes. Quantification of the amount of phospholipid and Au, and 
therefore by implication the amount of AuNPs, in each fraction eluted indicated that the 
AuNP elution mirrors that of the liposomes (as assessed by phospholipid concentration) with 
very small amounts of AuNPs being detected in the other fractions, suggesting that the 
majority of AuNPs were incorporated into the liposomes, i.e. there were very minimum free 
AuNPs (Figure S3 & S4). This was also confirmed with TEM imaging of L-AuNP before and 
after elution through sepharose CL-4B column which confirmed that no free AuNP 
aggregates exist before purification and suggested that most of the AuNPs already 
incorporated into the liposomes (Figure S4 C&D). This was consistent for all the L-AuNP 
samples prepared by MF and REV methodology. Correction of any loss of lipid vesicles on 
the SEC was performed by measuring the lipid concertation with Stewarts assay. In 
addition, the separation of empty (i.e. AuNPs free) liposomes from L-AuNP hybrids was 
explored by centrifugation during which the L-AuNP hybrids were sedimented due to the 
dense AuNPs they contained, while the empty liposomes remained suspended in the 
supernatant. Qualitative validation of these data was obtained using TEM imaging (Figure 
S5) which showed clearly the separation of the L-AuNP-containing liposomes from the 
empty liposomes. Dynamic light scattering measurements of the two fractions indicated, 
irrespective of the method of preparation, an increase in the apparent hydrodynamic size of 
the liposomes in the presence of AuNP with sizes in the range 130-260 nm being recorded 
for the L-AuNP hybrids compared to sizes of less than 100 nm for the empty liposomes 
(Table S1). 
The hybrids were also analysed by C-FFF, a technique which exploited both DLS and UV as 
detection methods which allowed the measurement of the apparent hydrodynamic size of 
particles and monitoring of the presence of any Au, respectively (Figure S5 C). When 
comparing the total particle population, the measured UV signal of the various liposomal 
preparations was found to be almost one order of magnitude higher for L-AuNP hybrids 
using MF methodology indicating higher AuNPs loading. Furthermore, the apparent 
difference in density    between the sample and solvent determined for the various 
liposomal preparations studied was particularly pronounced for the L-AuNP hybrids prepared 
using the highest initial concentration of Au of 2.5 mg/mL, with those prepared using MF 
exhibiting the highest density difference and therefore by implication the highest 
concentration of AuNPs. The fraction of loaded and unloaded liposomes expressed as wt % 
of the total liposomes prepared by MF and REV was also calculated (Figure S5D). Data 
indicated that the fraction of Loaded liposomes is higher for MF compared to REV for all 
AuNPs concentrations tested.
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Qualitative Evaluation of L-AuNP Hybrids with Electron Microscopy 
The morphological characterization of the L-AuNP hybrids was undertaken using 
transmission electron microscopy (Figure 4 A&B). The resultant TEM images confirmed the 
incorporation of AuNPs into the liposomes. Furthermore, in agreement with UV-VIS and ICP-
MS measurements, the TEM images revealed a higher AuNP loading capacity for the 
systems prepared by the MF method. Unfortunately, detection of AuNPs in the liposomes at 
the lowest initial concentration of Au was not possible. TEM images also revealed the 
presence of mixed population of both loaded and unloaded liposomes. The association of 
AuNPs with the liposomes was confirmed with STEM EDS microscopy (Figures 4C & D) 
which verified the association of Au with the liposomes by elemental analysis. A tendency 
towards the formation of nanoparticles rich domains was noticed in the MF L-AuNP hybrids 
samples compared to mainly individualised nanoparticles present in the lipid bilayer of the 
REV L-AuNP hybrids.
To further probe the association of Au nanoparticles with the liposomes, the L-AuNP hybrids 
were studied using cryo-TEM. CryoEM illustrates qualitative distinctions between the hybrid 
systems produced by the two methods when incorporating the highest initial amount of 
AuNPs. Specifically, the MF methodology provided hybrids that contained a core of AuNPs 
aggregates (Figure 4E). In these systems the core looks to be wrapped by a number of 
lipid bilayers which create a multilamellar structure around it. The cryo-TEM images of the 
MF prepared L-AuNP hybrids indicated the co-existence of membrane-embedded and 
interdigitated (i.e. encapsulated nanoparticles with some association of the internal lipid 
membrane) AuNP-rich domains suggesting the structural stabilization of the AuNPs 
hydrophobic interactions. These findings are in agreement with a recent work from Cullis 
group that reported the use of microfluidics to encapsulate negatively charges AuNP inside 
positively charged L-NP. However, in their case structural stabilisation of the final system is 
through electrostatic interactions 31. In contrast, the REV method was seen to result in the 
production of hybrids that predominately consist of two lipid bilayers and contain individual 
AuNPs or small aggregates of AuNPs (Figure 4F). Both unilamellar and multilamellar 
liposomes were present in the seen in the hybrids regardless of their preparation methods. 
Further CET studies performed on the L-AuNP hybrids prepared by MF confirmed the 
incorporation of AuNPs in the liposomes (Figure 5 & Supplementary Video). The ability to 
form multilamellar shell is very interesting and could have other possible applications such 
as increasing the loading efficiency of hydrophobic drugs. However, the factors responsible 
for controlling the number of layers in those multilamellar system and the effects of that on 
the physical properties of the final system need to be investigated. Nevertheless, since the 
% of nanoparticles incorporation into the lipid bilayer using the REV method is lower than 
MF, the overall effect of this incorporation on the lipid membrane fluidity is relatively minor. 
Effects of Au-NP Incorporation on Bilayer Thickness and Rigidity 
The effect of the presence of the AuNPs on the properties of the hybrid systems was 
established using a combination of advanced biophysical tools, namely fluorescence 
anisotropy, SANS and AFM. Anisotropy is widely used to study the effect of nanoparticles 
incorporation on lipid membrane packing and fluidity because of its high sensitivity to size, 
position, concentration of nanoparticles incorporated and sensitivity to experimental 
temperature conditions63, 64, 65. As a reflection of this enhancement in AuNPs incorporation, 
an increase in ANS fluorescence anisotropy values were observed indicating a reduction in 
the membrane fluidity or a rigidifying effect close to the head group region of the lipid 
membrane (Figures 6A &C). This effect was observed throughout the temperatures tested 
(i.e. below and above the Tm of the lipid membrane), particularly in the case of the hybrids 
prepared using MF methodology where there was a noticeable increased in anisotropy with 
initial AuNP concentration, suggesting that the bilayer rigidity close to the head group region 
was increased by increasing the concentration AuNP. In the hybrid systems prepared using 
the REV method, the anisotropy values were reduced and only in the case of the highest 
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initial AuNP concentration was an increase observed. Previous studies have demonstrated 
the ability of ANS molecules to penetrate the lipid bilayer and interact with the head group 
region on the inner and outer surface of the lipid bilayer 66, 67. Therefore, we expect that ANS 
anisotropy data to reflect the effect observed from both unilamellar and multilamellar vesicles 
in both methods. The effect of L-AuNPs hybrids size on membrane curvature and lipid 
packing might also affect ANS anisotropy data and should be taken in consideration when 
interpreting the results. 
On the contrary, minute changes were detected from DPH anisotropy demonstrating 
minimum nanoparticle association with the core of the lipid membrane (Figures 6B & D). No 
significant effect of changing the initial AuNP concentration was detected on the Tm of the 
liposomes when prepared using either methodology (Tm  ~50 °C for MF hybrids vs ~46 °C 
for REV hybrids). The lower Tm recorded from REV hybrids could be due to the presence of 
residual solvents that interdigitate in the lipid bilayer and results in distortion of lipid packing 
and hence reduced Tm compared to MF hybrids. The findings in the current study agree with 
previous studies reporting that the incorporation of small hydrophobic nanoparticles (< 5nm) 
increases membrane rigidity. On the contrary, nanoparticles bigger than 5 nm result in the 
distortion of the membrane effect causing an increase in lipid membrane fluidity23, 68.
In agreement with the anisotropy findings, SANS data (Figures 6E & F and Figure S6, Table 
3) indicated that the incorporation of AuNPs into the liposomes resulted in a slightly thicker 
(L = 49.1 ± 0.2 vs. 45.6 ± 0.1), more rigid bilayer (R/ = 560 vs 200) in the hybrid systems 
fabricated by the MF method and containing the highest initial load of AuNPs when 
compared to the corresponding hybrids prepared by the REV method and the empty 
liposomes. This observation may be a consequence of the differences in the loading 
efficiency between the two methods. SANS also indicated the co-existence of both 
unilamellar and multilamellar vesicles for both methods with the amount of multilamellar 
vesicles present being lower in the vesicles prepared using the MF methodology (Table 3) - 
a result that correlates well with the cryo-TEM findings.
Surface topography of L-AuNP hybrids was examined by AFM. Profile analysis performed 
using the AFM images (Figure 7) indicated that AuNP incorporation increased the height (i.e. 
thickness) of the lipid bilayer from 4-5 nm (empty liposomes) to almost 8-10 nm (L-AuNP 
hybrids) for both preparation methods tested at the highest initial AuNPs concentration. This 
result was in agreement with studies previously published by ourselves and others who 
reported an increase in the bilayer thickness after nanoparticle incorporation43, 69. 
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Table 3: Structural parameters obtained through fits to the SANS data obtained for 
vesicle dispersions prepared from the various liposomal preparations at 25 ± 0.1° C. 
Symbols used are as described in the text
Liposomal 
preparations
Mean 
bilayer 
thickness 
(L)
Å
The 
Lorentz 
factor 
"(5$
Å
Mean 
separation or 
d-spacing (D)
Å
Number of 
bilayers in 
the stack 
(M)
Ratio of 
Unilamellar: 
Multilamellar 
surface area
Empty 
liposomes
45.6(0.1) 200 64.9 ± 0.2 3 1.5
MF L-AuNP 2.5 49.1(0.2) 560 72.5 ± 0.3 4 2.7
REV L-AuNP 
2.5
45.6(0.1) 200 64.9 ± 0.2 3 1.4
For L, the figures in parentheses show standard errors; for D, the uncertainties reported represent 
the convolution of the statistical error on D and the value of the fitted polydispersity.
Overall, our structural characterization corroborated the two proposed models of AuNP 
association with the liposomes, namely the membrane embedded and the encapsulated 
models. In agreement with TEM images, a mixed population of AuNP loaded and unloaded 
liposomes were detected. In the case of the MF L-AuNP hybrids, the co-existence of lipid 
bilayer embedded AuNPs (i.e. the membrane embedded model) and AuNPs inside the 
liposomes (i.e. the encapsulated model) with some interaction with internal lipid membrane 
was observed. In contrast, membrane embedded AuNPs were found to exist in the majority 
of REV L-AuNP hybrids with a minority of encapsulated AuNPs being observed. SANS and 
AFM observations reinforced anisotropy measurements that confirm the increase in the 
bilayer thickness for MF L-AuNP hybrids systems. 
Optimization processes reported here are all based on one specific instrument (Asia 320 
microfluidic system). Whether the process can translate and expand to other types of 
microfluidic systems requires further investigation. 
Collectively, our results demonstrate that by using a microfluidic method of preparation we 
were able to improve the loading of hydrophobic metallic NPs into liposomes when 
compared to the traditional REV method. The results obtained in this study using a 
commercial microfluidics system enables the reproducible, automated manufacture of L-
AuNP hybrids. Other critical factors that may be worth exploring in the future are the effect 
this enhanced loading could have on the encapsulation efficiency of imaging and/or 
theranostic systems. More work needs to be undertaken to prove that the enhanced payload 
of AuNP observed in the L-AuNP hybrids can be translated into a higher efficiency for such 
systems. Moreover, the concentration AuNP loaded inside the liposomes should be carefully 
selected to ensure that theranostic properties of AuNP is not lost due to possible 
aggregation if very high concentration is loaded.
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Conclusions
We have demonstrated for the first time the fabrication of L-AuNP hybrids using automated 
microfluidic technology. The L-AuNP hybrids prepared in the present study showed a more 
homogenous size distribution and correspondingly smaller PDI compared to those made 
using the traditional REV methodology. Most significantly, the capacity of the nanoparticles 
prepared using microfluidic technology for its AuNPs payload was three times that of the 
REVs prepared using traditional methodology. Detailed structural characterisation of the L-
AuNP hybrids using a range of advance biophysical methods confirmed the superiority of the 
microfluidics for the preparation of nanoparticle-containing liposomes. The data also 
revealed the co-existence of membrane embedded and interdigitated nanoparticles-rich 
domains which are understood to be a consequence of both the size of the AuNPs studied 
and their hydrophobic nature. The present findings demonstrate the benefit that microfluidic 
technology offers in the preparation of hybrid nanoparticles with improved fabrication and 
functionality and to expedite their translation for imaging and/or therapeutic purposes.
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Figure 3: Quantification of the loading capacity of L-AuNP hybrids by the microfluidic (MF) and the 
reverse phase evaporation (REV) methods with different initial amounts of AuNP, namely 0.025, 0.25 
and 2.5 mg/mL as determined by A) UV-VIS spectrophotometry and B) inductively coupled plasma 
mass spectrometry (ICP-MS). Data are expressed as a wt% gold (Au) per wt lipid. Quantification of 
lipid concentration in each sample was performed by Stewarts assay. Samples measured at room 
temperature, n = 3 for UV measurements and n=2 for ICP-MS measurements.
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Figure 4: Characterisation of L-AuNP hybrids by electron microscopy. TEM images of L-AuNP 
hybrids prepared by A) MF method and B) REV method with different initial amounts of AuNP, namely 
0.025, 0.25 and 2.5 mg/mL. It was not possible using TEM to detect AuNPs in the liposomes with the 
lowest amount of AuNPs. HAADF image of L-AuNP hybrids 0.25 prepared by CI) MF and DI) REV 
methods highlighting inside the green box representative regions of with liposomes containing 
aggregates of AuNPs (MF method) and a small number of individual nanoparticles (REV method). Au-
L and U-L composite elemental (Au and U) map obtained by XEDS and simultaneously acquired 
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HAADF images of the highlighted area of L-AuNP hybrids prepared by the MF method CII) and CIII) 
and the REV method DII) and DIII). XEDS spectra show Au from the AuNPs in blue and the area 
surrounding the AuNPs in orange. CryoEM images of L-AuNP hybrids prepared by E) the MF method 
and F) and the REV method with an initial amount of AuNP, namely 2.5 mg/mL. The scale bars for CI) 
and DI) is 200 nm; for C-II) and C-III) is 20 nm; and D-II) and D-III) is 10 nm; E) is 100 nm; F) = 50 nm 
(left) & 10 nm (right).
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Figure 5: 3D model obtained from the cryo-tomography performed on a multilamellar liposome 
produced by the MF method. On the right, two z-stack images are provided. It was possible to 
observe the multilamellar structure (black arrows point the different phospholipid layers) and to 
demonstrate that the Au-NP agglomerate is incorporated into the liposome. Scale bar = 100nm. 
Please, note that the 3D model has been segmented in order to remove unwanted artefact (see 
Supplementary Video).  
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Figure 7: Characterisation of empty liposomes (plain L) and L-AuNP hybrids (MF L-AuNP 2.5 and 
REV L-AuNP 2.5) by atomic force microscopy showing A) amplitude, B) 3D images and C) cross-
section analysis). Measurements performed at 25°C.
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